Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Burgess

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 13, 2010
Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokersBrent Caldwell, Carl Burgess, Julian Crane
The New Zealand Medical Journal|May 19, 2009
High blood pressure advice given by natural health food storesRobert Siebers, Shaun Holt, Bridget Healy, et al.
Therapeutics and Clinical Risk Management|May 20, 2008
The use of antithrombotics in patients presenting with stroke and atrial fibrillationCarl Burgess, Tristram Ingham, Martin Woodbridge, et al.
The New Zealand Medical Journal|October 19, 2002
Do natural health food stores require regulation?Bridget Healey, Carl Burgess, Robert Siebers, et al.
Lancet (London, England)|June 27, 2003
Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trialRodney Hughes, Alexandra Goldkorn, Matthew Masoli, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 7, 2009
A pilot study of nicotine delivery to smokers from a metered-dose inhalerBrent Caldwell, Stuart Dickson, Carl Burgess, et al.
Respirology (Carlton, Vic.)|February 26, 2004
The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamolAlexandra Goldkorn, Patricia Diotto, Carl Burgess, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2021
Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trialMichael O'Rawe, Agadha C Wickremesekera, Ramesh Pandey, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 13, 2010
Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokersBrent Caldwell, Carl Burgess, Julian Crane
The New Zealand Medical Journal|May 19, 2009
High blood pressure advice given by natural health food storesRobert Siebers, Shaun Holt, Bridget Healy, et al.
Therapeutics and Clinical Risk Management|May 20, 2008
The use of antithrombotics in patients presenting with stroke and atrial fibrillationCarl Burgess, Tristram Ingham, Martin Woodbridge, et al.
The New Zealand Medical Journal|October 19, 2002
Do natural health food stores require regulation?Bridget Healey, Carl Burgess, Robert Siebers, et al.
Lancet (London, England)|June 27, 2003
Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trialRodney Hughes, Alexandra Goldkorn, Matthew Masoli, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 7, 2009
A pilot study of nicotine delivery to smokers from a metered-dose inhalerBrent Caldwell, Stuart Dickson, Carl Burgess, et al.
Respirology (Carlton, Vic.)|February 26, 2004
The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamolAlexandra Goldkorn, Patricia Diotto, Carl Burgess, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2021
Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trialMichael O'Rawe, Agadha C Wickremesekera, Ramesh Pandey, et al.
Pageof 1